earnings
revenue
profit
loss
guidance
forecast
outlook
quarterly report
annual report
results
missed estimates
beat estimates
record high
record low
acquire
acquisition
merger
takeover
divest
spin-off
buyout
stake
lawsuit
litigation
investigation
settlement
fda approval
doj
sec
ftc
antitrust
probe
ruling
patent infringement
ceo
cfo
cto
coo
resigns
steps down
appoints
departure
succession
layoffs
restructuring
workforce reduction
product launch
new product
recall
data breach
outage
cyberattack
clinical trial results
phase iii
fda rejection
ipo
stock split
buyback program
share repurchase
offering
dividend
bankruptcy
debt
credit rating
liquidity